Plus Therapeutics Regains Compliance with Nasdaq Minimal Bid Worth Requirement
HOUSTON, April 21, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV)…
Artelo Biosciences Regains Compliance with Nasdaq Record Necessities
SOLANA BEACH, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc.…
Denali Therapeutics Regains Complete Rights to Investigational Treatment DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN)
Denali plans to proceed medical building of DNL593, which is designed to…
